Erythropoietin treatment is associated with an augmented immune response to the influenza vaccine in hematologic patients
Authors:
- Sara Prutchi-SagivSPSara Prutchi-Sagiv
- Ora HalutzOHOra Halutz
- Esther ShabtaiESEsther Shabtai
- Michael HoffmanMHMichael Hoffman
- Drorit NeumannDNDrorit Neumann
- Moshe MittelmanMMMoshe Mittelman
- 1 February 2013
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 41 (2) , 167-171
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Update on Erythropoiesis-Stimulating Agents and Clinical Trials in OncologyThe Oncologist, 2009
- Impact of epoetin‐β on survival of patients with lymphoproliferative malignancies: long‐term follow up of a large randomized study*British Journal of Haematology, 2005
- Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findingsNeurosurgical Review, 2004
- Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia‐reperfusion injuryThe FASEB Journal, 2004
- A novel protective effect of erythropoietin in the infarcted heartJournal of Clinical Investigation, 2003
- Erythropoietin crosses the blood–brain barrier to protect against experimental brain injuryProceedings of the National Academy of Sciences, 2000
- Recombinant human erythropoietin and the anemia of cancer [editorial]Blood, 1994
- Erythropoietin receptor mRNA expression in human endothelial cells.Proceedings of the National Academy of Sciences, 1994
- ErythropoietinNew England Journal of Medicine, 1991
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989